OLP Therapeutics, an Oakland, California startup, has released its first product line: natural, unaltered psilocybin mushroom medicines with exact, standardized quantities of active ingredients.
Read More
While there has been very promising evidence of safety and effectiveness for psychedelics after a few acute macrodoses in clinical trials, the risks and benefits of chronic microdosing still remain largely unknown.
Read More